Debra Fenderson-Ivery
Adult Health · Hainesport, NJNPI 1902306624
Payments from drug & device makers
Across 181 payments — averaging $20.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$472
- Abbott$460
- Protega Pharmaceutials Inc$355
- Scilex Pharmaceuticals Inc.$237
- Averitas Pharma Inc.$226
- plus $764 from 16 others
What the payments were for
- Food & beverage$3,667100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 82 | $1,154 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $472 |
| Abbott | 12 | $460 |
| Protega Pharmaceutials Inc | 16 | $355 |
| Scilex Pharmaceuticals Inc. | 11 | $237 |
| Averitas Pharma Inc. | 3 | $226 |
| Boston Scientific | 3 | $200 |
| Saluda Medical Americas, Inc. | 4 | $117 |
| Vertos Medical, Inc. | 2 | $73 |
| Teva Pharmaceuticals USA, Inc. | 4 | $57 |
| Valinor Pharma, LLC | 3 | $54 |
| Forte Bio-pharma LLC | 3 | $50 |
| Foundation Fusion Solutions, LLC | 2 | $40 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Almatica Pharma LLC | 2 | $28 |
| Redhill Biopharma Inc. | 2 | $25 |
| Pfizer | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $15 |
| GRT US Holding, Inc. | 1 | $15 |
| AbbVie | 1 | $14 |
| GSK | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Roxybond$133
- Qutenza$122
- WAVEWRITER ALPHA$114
- RELISTOR$106
- PROCLAIM$104
How this compares
$3,667 in reported general payments places this provider in the 90th percentile of 1,135 adult health providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZtlidoLidocaine | 159 | $144,978 |
| PercocetOxycodone Hcl/Acetaminophen | 41 | $143,199 |
| BelbucaBuprenorphine Hcl | 108 | $86,254 |
| RelistorMethylnaltrexone Bromide | 36 | $84,821 |
| Xtampza ErOxycodone Myristate | 106 | $44,058 |
| Nucynta ErTapentadol Hcl | 53 | $36,334 |
| OxycontinOxycodone Hcl | 62 | $27,978 |
| Diclofenac Sodium | 130 | $22,599 |
| Lidocaine | 112 | $18,857 |
| Buprenorphine | 88 | $16,760 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 786 | $15,928 |
| Oxycodone Hcl | 619 | $12,693 |
| LicartDiclofenac Epolamine | 11 | $8,420 |
| MovantikNaloxegol Oxalate | 18 | $7,311 |
| SymproicNaldemedine Tosylate | 14 | $6,241 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta Er | $1,154 | $166,645267 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $237 | $144,978159 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $472 | $84,82136 claims |
| IBSA Pharma Inc.Licart | $15 | $8,42011 claims |
| Redhill Biopharma Inc.Movantik | $25 | $7,31118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,135 adult health providers in New Jersey.
Other adult health in Hainesport
- June HalperHackensack$458K
- Kara SaggiomoCamden$127K
- Entela AhmetiPomona$75K
- Phyllis McKiernanHackensack$72K
- Denise ForceMiddletown$71K
- Kathleen SenecaHillsborough$64K
- Diane AndresenNorthvale$60K
- Dana BeenstockFreehold$51K
- Phyllis DudaCamden$46K
- Anthony WalkoWestwood$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.